Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving virus or bacteriophage
Reexamination Certificate
2004-06-14
2009-12-15
Helms, Larry R (Department: 1648)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving virus or bacteriophage
C435S006120, C435S007400, C435S023000, C435S024000, C536S023100
Reexamination Certificate
active
07632635
ABSTRACT:
A search method in a biological sample containing an HIV 2 viral strain for possible resistance of said strain to treatment by an anti-protease agent, and nucleotide probes for the implementation thereof. According to methods known per se, the presence of at least one mutation at certain, specified, particular positions of the proteinic sequence of the protease of said viral strain from a biological sample taken from a patient contaminated by HIV 2 is searched. If said mutation is observed, the existence of a resistance to said anti-protease agent is assumed in the patient.
REFERENCES:
patent: 5436131 (1995-07-01), Condra et al.
patent: 5786177 (1998-07-01), Moncany et al.
patent: 6087093 (2000-07-01), Lieven et al.
patent: WO 90 14842 (1990-12-01), None
patent: WO 96 08580 (1996-03-01), None
patent: WO 99 38961 (1999-08-01), None
patent: WO 99 67428 (1999-12-01), None
Le Grice, et al. Comparison of the Human Immunodeficiency Virus Type 1 and 2 proteases by Hybrid Gene Construction and trans-complementation. The Journal of Biological Chemistry Sep. 5, 1989, vol. 264, No. 25, pp. 14902-14908.
Doyon et al. Second Locus Involved in Human Immunodeficiency Virus Type 1 Resistance to Protease Inhibitors. Journal of Virology Jun. 1996, vol. 70, No. 6, p. 3763-3769.
Chen et al. Crystal Structure at 1.9-Angstrom Resolution of Human Immunodeficiency Virus (HIV) II Protease Complexed with L-735,524, an Orally Bioavailable Inhibitor of the HIV Proteases, The Journal of Biological Chemistry, Oct 21, 1994, vol. 269, No. 42, pp. 26344-26348.
J.R. Rose et al., “Regulation of Autoproteolysis of the HIV-1 and HIV-2 Proteases with Engineered Amino Acid Substitutions,”The Journal of Biological Chemistry, vol. 268, No. 16, pp. 11939-11945, 1993.
Melnick et al., “AnEscherichia coliexpression assay andscreen for immunodeficiency virus protease variants with decreased susceptibility to indinavir”, Antimicrobial Agents and Chemotherapy, vol. 42, No. 12, 1998, pp. 3256-3265.
Vasudevachari et al., “Emergence of protease inhibitor resistance mutations in human immunodeficiency virus type 1 isolates from patients and rapid screening procedure for their detection” Antimicrobial Agents and Chemotherapy vol. 40, No. 11, 1996, pp. 2535-2541.
Maschera et al, “Analysis of resistance to human immunodeficiency virus type 1 protease inhibitors by using matched bacterial expression and proviral infection vectors” Journal of Virology vol. 69, No. 9, 1995, pp. 5431-5436.
Martinez-Picado et al., “Replicative fitness of protease inhibitor-resistant mutant of human immunodeficiency virus type 1” Journal of Virology, US, The American Society for Microbiology, vol. 73, No. 5, May 1999, pp. 3744-3752.
Brun-Vezinet Francoise
Descamps Diane
Telles Jean-Noel
Assistance Publique-Hopitaux de Paris
Biomerieux
Helms Larry R
Humphrey Louise
Oliff & Berridg,e PLC
LandOfFree
Method for measuring resistance of a patient HIV-2 to... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for measuring resistance of a patient HIV-2 to..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for measuring resistance of a patient HIV-2 to... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4098568